Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. (EUCR) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 3 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Nov 24, 2020 involved a transaction of 255,094 shares valued at $0.
EUCR Insider Activity Summary
Who Is Buying EUCR Stock?
No significant insider buying has been recorded for EUCR in the recent period.
Who Is Selling EUCR Stock?
No significant insider selling has been recorded for EUCR in the recent period.
Is Eucrates Biomedical Acquisition Corp. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EUCR is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
EUCR Frequently Asked Questions
Understanding EUCR Insider Activity
Insider trading at Eucrates Biomedical Acquisition Corp. (EUCR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading EUCR stock, having executed 3 transactions in the past 90 days. The most active insider is Llc Eucrates (Executive), who has made 1 transactions totaling $0.
Related Tools
Track Eucrates Biomedical Acquisition Corp. Insider Activity
Get notified when executives and directors at EUCR file new Form 4 transactions